编辑专栏文章 - 后台系统

编辑专栏文章

编辑专栏文章

文章标题：

标　　签：

关键字：

药品词链接：

插入此药品介绍区块

文章分类：

文章主图*

点击“Select image”更换图片

Select image Change Remove

注意! 最佳图片尺寸200*200

将主图插入到内容

内容详情：

<p style="margin:0pt 0pt 0.0001pt; text-align:justify"><span style="font-size:10.5pt"><span style="font-family:Calibri"><span style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="color:#000000"><span style="letter-spacing:0.0000pt"><span style="text-transform:none"><span style="font-style:normal"><font face="微软雅黑">前列腺癌（</font>prostate cancer,PCa）是导致男性死亡的排名第二的恶性肿瘤,并在所有的肿瘤特异性死亡中排在第五,每年由PCa引起的死亡超过三十万,占男性癌症特异性死亡率的6.6%。</span></span></span></span></span></span></span></span></span></p>

<p style="margin:0pt 0pt 0.0001pt; text-align:justify"> </p>

<p style="margin:0pt 0pt 0.0001pt; text-align:justify"><span style="font-size:10.5pt"><span style="font-family:Calibri"><span style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="color:#000000"><span style="letter-spacing:0.0000pt"><span style="text-transform:none"><span style="font-style:normal">去势治疗是晚期PCa常用的治疗方式,但也很容易产生治疗抗性,去势抵抗前列腺癌（castration-resistant prostate cancer,CRPC）患者的5年生存率仅有25.4%。恩杂鲁胺是治疗CRPC的新药,其主要作用是抑制雄激素受体（androgen receptor,AR）入核,然而基因突变</span></span></span></span></span></span></span></span></span></p>

<p style="margin:0pt 0pt 0.0001pt; text-align:justify"> </p>

<p style="margin:0pt 0pt 0.0001pt; text-align:justify"> </p>

<p style="margin:0pt 0pt 0.0001pt; text-align:justify"><span style="font-size:10.5pt"><span style="font-family:Calibri"><a href="https://www.jingrenjiankang.com/drug_detail-6-12.html"><b><span style="font-size:12.0000pt"><span style="background:#ffff00"><span style="font-family:微软雅黑"><span style="font-weight:bold"><font face="微软雅黑">阿比特龙</font></span></span></span></span></b></a><span style="font-size:12.0000pt"><span style="font-family:微软雅黑"><font face="微软雅黑">耐药了，可以选择</font></span></span><b><span style="font-size:12.0000pt"><span style="background:#ffff00"><span style="font-family:微软雅黑"><span style="font-weight:bold"><font face="微软雅黑">恩杂鲁胺</font></span></span></span></span></b><span style="font-size:12.0000pt"><span style="font-family:微软雅黑"><font face="微软雅黑">吗？</font></span></span><span style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="color:#000000"><span style="letter-spacing:0.0000pt"><span style="text-transform:none"><span style="font-style:normal"><font face="微软雅黑">阿比特龙（通用商品名</font>:泽珂）是一种CYP17抑制剂,对晚期（转移性）前列腺癌非常有效,2015年,国内正式获批上市。</span></span></span></span></span></span></span></span></span></p>

<p style="margin:0pt 0pt 0.0001pt; text-align:justify"><span style="font-size:10.5pt"><span style="font-family:Calibri"><span style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="color:#000000"><span style="letter-spacing:0.0000pt"><span style="text-transform:none"><span style="font-style:normal"><font face="微软雅黑">随着国产阿比特的上市及医保报销的覆盖</font>,越来越多的晚期患者有条件服用阿比特龙。但随着用药时间的推移,阿比特龙会出现失效现象,即癌细胞对阿比特龙产生了耐药。 </span></span></span></span></span></span></span></span></span></p>

<p style="margin:0pt 0pt 0.0001pt; text-align:justify"> </p>

<p style="margin:0pt 0pt 0.0001pt; text-align:justify"> </p>

<p style="margin:0pt 0pt 0.0001pt; text-align:justify"><span style="font-size:10.5pt"><span style="font-family:Calibri"><span style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="color:#000000"><span style="letter-spacing:0.0000pt"><span style="text-transform:none"><span style="font-style:normal"><font face="微软雅黑">印度版的阿比特龙目前价格是一千多，性价比高，如果您有关于靶向药阿比特龙、恩杂鲁胺方面的疑问，可直接致电鲸人健康</font></span></span></span></span></span></span></span></span></span></p>

<p style="margin:0pt 0pt 0.0001pt; text-align:justify"><span style="font-size:10.5pt"><span style="font-family:Calibri"><span style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="color:#000000"><span style="letter-spacing:0.0000pt"><span style="text-transform:none"><span style="font-style:normal"><font face="微软雅黑">顾问热线：</font></span></span></span></span></span></span></span><b><span style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="color:#000000"><span style="letter-spacing:0.0000pt"><span style="font-weight:bold"><span style="text-transform:none"><span style="font-style:normal"><font face="微软雅黑">18515676770/15321833786</font></span></span></span></span></span></span></span></span></b><span style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="color:#000000"><span style="letter-spacing:0.0000pt"><span style="text-transform:none"><span style="font-style:normal"><font face="微软雅黑">（微信同号）</font></span></span></span></span></span></span></span></span></span></p>

<p> </p>

<p><img alt="" src="../upload/62b400340983c824866115.png" style="width: 488px; height: 262px;" /></p>

<p> </p>

<p> </p>

<p> </p>

<p>鲸人健康是国内大型国际医疗服务平台，竭诚为您服务。</p>

<p>更多关于<a href="https://www.jingrenjiankang.com/drug_detail-6-13.html"><span style="color:#2980b9;"><strong>恩杂鲁胺</strong></span></a>，请直接致电鲸人医疗专家热线：18515676770/15321833786</p>

首页显示：

显示不显示

热门文章：

是否

阅读：

定时发送：

否是